M E Egger

Summary

Affiliation: University of Bern
Country: Switzerland

Publications

  1. ncbi Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South Africa
    Mhairi Maskew
    Clinical HIV Research Unit, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand York Avenue, Johannesburg 2193, South Africa
    Infect Agent Cancer 6:22. 2011
  2. ncbi Cardiovascular mortality and exposure to extremely low frequency magnetic fields: a cohort study of Swiss railway workers
    Martin Röösli
    Institute of Social and Preventive Medicine ISPM, University of Bern, Finkenhubelweg 11, 3012 Bern, Switzerland
    Environ Health 7:35. 2008
  3. ncbi Graphical presentation of diagnostic information
    Penny F Whiting
    Department of Social Medicine, Canynge Hall, Whiteladies Road, Bristol, BS8 2PR, UK
    BMC Med Res Methodol 8:20. 2008
  4. ncbi Development, feasibility and performance of a health risk appraisal questionnaire for older persons
    Andreas E Stuck
    Department of Geriatrics, University of Bern, Spital Bern Ziegler, Morillonstrasse 75 91, CH 3001 Bern, Switzerland
    BMC Med Res Methodol 7:1. 2007
  5. ncbi The PRO-AGE study: an international randomised controlled study of health risk appraisal for older persons based in general practice
    Andreas E Stuck
    University Department of Geriatrics, Spital Bern Ziegler, Morillonstrasse 75 91, CH 3001 Bern, Switzerland
    BMC Med Res Methodol 7:2. 2007
  6. ncbi Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies
    Matthias Egger
    Department of Social and Preventive Medicine, University of Bern, CH 3012 Bern, Switzerland
    Lancet 360:119-29. 2002
  7. ncbi Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies
    G Chene
    Department of Social and Preventive Medicine, University of Bern, Finkenhubelweg 11, CH 3012, Bern, Switzerland
    Lancet 362:679-86. 2003
  8. ncbi Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa
    Matthias Egger
    Institute of Social and Preventive Medicine ISPM, University of Bern, Switzerland
    PLoS Med 8:e1000390. 2011
  9. ncbi Population effect of scaling up ART in resource-poor settings
    Matthias Egger
    International epidemiological Databases to Evaluate AIDS (IeDEA, Infectious Disease Epidemiology Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
    Lancet 371:1558-9. 2008
  10. ncbi Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America
    Olivia Keiser
    Institute of Social and Preventive Medicine ISPM, University of Bern, Finkenhubelweg 11, 3012 Bern, Switzerland
    Trop Med Int Health 13:870-9. 2008

Research Grants

  1. Observational Antiretroviral Studies In Southern Africa (OASIS) Collaboration
    Matthias Egger; Fiscal Year: 2007
  2. Observational Antiretroviral Studies In Southern Africa (OASIS) Collaboration
    Matthias Egger; Fiscal Year: 2007

Detail Information

Publications95

  1. ncbi Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South Africa
    Mhairi Maskew
    Clinical HIV Research Unit, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand York Avenue, Johannesburg 2193, South Africa
    Infect Agent Cancer 6:22. 2011
    ..abstract:..
  2. ncbi Cardiovascular mortality and exposure to extremely low frequency magnetic fields: a cohort study of Swiss railway workers
    Martin Röösli
    Institute of Social and Preventive Medicine ISPM, University of Bern, Finkenhubelweg 11, 3012 Bern, Switzerland
    Environ Health 7:35. 2008
    ..We examined mortality from cardiovascular causes in railway workers exposed to varying degrees to intermittent 16.7 Hz magnetic fields...
  3. ncbi Graphical presentation of diagnostic information
    Penny F Whiting
    Department of Social Medicine, Canynge Hall, Whiteladies Road, Bristol, BS8 2PR, UK
    BMC Med Res Methodol 8:20. 2008
    ..Diagnostic information should be presented in an easily interpretable way, which conveys both test characteristics (diagnostic accuracy) and the potential for use in clinical practice (predictive value)...
  4. ncbi Development, feasibility and performance of a health risk appraisal questionnaire for older persons
    Andreas E Stuck
    Department of Geriatrics, University of Bern, Spital Bern Ziegler, Morillonstrasse 75 91, CH 3001 Bern, Switzerland
    BMC Med Res Methodol 7:1. 2007
    ..Health risk appraisal is a promising method for health promotion and prevention in older persons. The Health Risk Appraisal for the Elderly (HRA-E) developed in the U.S. has unique features but has not been tested outside the United States...
  5. ncbi The PRO-AGE study: an international randomised controlled study of health risk appraisal for older persons based in general practice
    Andreas E Stuck
    University Department of Geriatrics, Spital Bern Ziegler, Morillonstrasse 75 91, CH 3001 Bern, Switzerland
    BMC Med Res Methodol 7:2. 2007
    ..This paper describes the study protocol, the recruitment, and base-line data for evaluating the success of randomisation of the PRO-AGE (PRevention in Older people-Assessment in GEneralists' practices) project...
  6. ncbi Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies
    Matthias Egger
    Department of Social and Preventive Medicine, University of Bern, CH 3012 Bern, Switzerland
    Lancet 360:119-29. 2002
    ..The ART Cohort Collaboration, which includes 13 cohort studies from Europe and North America, was established to fill this knowledge gap...
  7. ncbi Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies
    G Chene
    Department of Social and Preventive Medicine, University of Bern, Finkenhubelweg 11, CH 3012, Bern, Switzerland
    Lancet 362:679-86. 2003
    ..We examined whether the initial virological and immunological response to highly active antiretroviral treatment (HAART) is prognostic in patients with HIV-1 who start HAART...
  8. ncbi Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa
    Matthias Egger
    Institute of Social and Preventive Medicine ISPM, University of Bern, Switzerland
    PLoS Med 8:e1000390. 2011
    ..As mortality is high in these patients compared to patients remaining in care, ART programmes with high rates of loss to follow-up may substantially underestimate mortality of all patients starting ART...
  9. ncbi Population effect of scaling up ART in resource-poor settings
    Matthias Egger
    International epidemiological Databases to Evaluate AIDS (IeDEA, Infectious Disease Epidemiology Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
    Lancet 371:1558-9. 2008
  10. ncbi Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America
    Olivia Keiser
    Institute of Social and Preventive Medicine ISPM, University of Bern, Finkenhubelweg 11, 3012 Bern, Switzerland
    Trop Med Int Health 13:870-9. 2008
    ..To describe temporal trends in baseline clinical characteristics, initial treatment regimens and monitoring of patients starting antiretroviral therapy (ART) in resource-limited settings...
  11. ncbi Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring
    Olivia Keiser
    Institute of Social and Preventive Medicine ISPM, University of Bern, Bern, Switzerland
    AIDS 23:1867-74. 2009
    ..We examined switching from nonnucleoside reverse transcriptase inhibitor (NNRTI)-based first-line regimens to protease inhibitor-based regimens in Africa, South America and Asia...
  12. ncbi Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries
    Martin W G Brinkhof
    Institute of Social and Preventive Medicine, Bern, Switzerland
    Bull World Health Organ 86:559-67. 2008
    ..To analyse the early loss of patients to antiretroviral therapy (ART) programmes in resource-limited settings...
  13. ncbi Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings
    Mathieu Forster
    Institute of Social and Preventive Medicine, University of Bern, Switzerland
    Bull World Health Organ 86:939-47. 2008
    ....
  14. ncbi The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
    Erik von Elm
    Institute of Social and Preventive Medicine ISPM, University of Bern, Bern, Switzerland
    Lancet 370:1453-7. 2007
    ..We hope that the STROBE statement will contribute to improving the quality of reporting of observational studies..
  15. ncbi The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
    Erik von Elm
    Institute of Social and Preventive Medicine, University of Bern, 3012 Bern, Switzerland
    J Clin Epidemiol 61:344-9. 2008
    ..We hope that the STROBE Statement will contribute to improving the quality of reporting of observational studies...
  16. ncbi Temporal and spatial variability of personal exposure to radio frequency electromagnetic fields
    Patrizia Frei
    Institute of Social and Preventive Medicine, University of Bern, Switzerland
    Environ Res 109:779-85. 2009
    ..Little is known about the population's exposure to radio frequency electromagnetic fields (RF-EMF) in industrialized countries...
  17. ncbi Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared
    Olivia Keiser
    Institute of Social and Preventive Medicine ISPM, University of Bern, Bern, Switzerland
    PLoS Med 5:e148. 2008
    ..We compared virologic response, changes to first-line regimens, and mortality in HIV-infected patients starting HAART in South Africa and Switzerland...
  18. ncbi The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
    Erik von Elm
    Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
    Bull World Health Organ 85:867-72. 2007
    ..We hope that the STROBE Statement will contribute to improving the quality of reporting of observational studies...
  19. ncbi The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
    Erik von Elm
    Institute of Social and Preventive Medicine ISPM, University of Bern, Bern, Switzerland
    Epidemiology 18:800-4. 2007
    ..We hope that the STROBE Statement will contribute to improving the quality of reporting of observational studies...
  20. ncbi The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
    Erik von Elm
    Institute of Social and Preventive Medicine ISPM, University of Bern, Finkenhubelweg 11, CH 3012 Bern, Switzerland
    Prev Med 45:247-51. 2007
    ..We hope that the STROBE Statement will contribute to improving the quality of reporting of observational studies...
  21. ncbi Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
    Erik von Elm
    Institute of Social and Preventive Medicine, University of Bern, Finkenhubelweg 11, CH-3012 Bern, Switzerland
    BMJ 335:806-8. 2007
  22. ncbi The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
    Erik von Elm
    Institute of Social and Preventive Medicine ISPM, University of Bern, Bern, Switzerland
    PLoS Med 4:e296. 2007
    ..We hope that the STROBE Statement will contribute to improving the quality of reporting of observational studies...
  23. ncbi The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
    Erik von Elm
    Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
    Ann Intern Med 147:573-7. 2007
    ..annals.org and on the Web sites of PLoS Medicine and Epidemiology. We hope that the STROBE Statement will contribute to improving the quality of reporting of observational studies...
  24. ncbi Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial
    Peter Juni
    University of Berne, Berne, Switzerland
    Arthritis Rheum 56:3610-9. 2007
    ..To compare the efficacy and safety of intraarticular hylan and 2 hyaluronic acids (HAs) in osteoarthritis (OA) of the knee...
  25. ncbi [The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies]
    Erik von Elm
    Institute of Social and Preventive Medicine ISPM, University of Bern, Berna, Switzerland
    Gac Sanit 22:144-50. 2008
    ..We hope that the STROBE statement will contribute to improving the quality of reporting of observational studies...
  26. ncbi Statistical analysis of personal radiofrequency electromagnetic field measurements with nondetects
    Martin Röösli
    Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
    Bioelectromagnetics 29:471-8. 2008
    ..Nevertheless, estimates of source-specific medians or even lower percentiles depend on the assumed data distribution and should be considered with caution...
  27. ncbi Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa
    Lukas Fenner
    Institute of Social and Preventive Medicine, University of Bern, Switzerland
    J Acquir Immune Defic Syndr 54:524-32. 2010
    ..We analyzed mortality in children retained in care and in all children starting ART, taking LTFU into account...
  28. ncbi Population based screening - the difficulty of how to do more good than harm and how to achieve it
    Marcel Zwahlen
    Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
    Swiss Med Wkly 140:w13061. 2010
    ..Without explicit processes there is a danger that beneficial screening programmes could be neglected and that ineffective, and potentially harmful, screening procedures could be introduced...
  29. ncbi Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration
    Morna Cornell
    Infectious Disease Epidemiology Unit, School of Public Health and Family Medicine, University of Cape Town
    S Afr Med J 99:653-60. 2009
    ....
  30. ncbi Suicide in HIV-infected individuals and the general population in Switzerland, 1988-2008
    Olivia Keiser
    Institute of Social and Preventive Medicine ISPM, University of Bern, Finkenhubelweg 11, CH 3012 Bern, Switzerland
    Am J Psychiatry 167:143-50. 2010
    ..The authors examined time trends and predictors of suicide in the pre-HAART (1988-1995) and HAART (1996-2008) eras in HIV-infected patients and the general population in Switzerland...
  31. ncbi Mortality after failure of antiretroviral therapy in sub-Saharan Africa
    Olivia Keiser
    Institute of Social and Preventive Medicine ISPM, University of Bern, Bern, Switzerland
    Trop Med Int Health 15:251-8. 2010
    ..To assess the outcome of patients who experienced treatment failure with antiretrovirals in sub-Saharan Africa...
  32. ncbi Residence near power lines and mortality from neurodegenerative diseases: longitudinal study of the Swiss population
    Anke Huss
    Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
    Am J Epidemiol 169:167-75. 2009
    ..00 (95% CI: 1.21, 3.33) with at least 15 years. The pattern was similar for senile dementia. There was little evidence for an increased risk of amyotrophic lateral sclerosis, Parkinson's disease, or multiple sclerosis...
  33. ncbi Accuracy of WHO CD4 cell count criteria for virological failure of antiretroviral therapy
    Olivia Keiser
    Institute of Social and Preventive Medicine ISPM, University of Bern, CH 3012 Bern, Switzerland
    Trop Med Int Health 14:1220-5. 2009
    ..To examine the accuracy of the World Health Organization immunological criteria for virological failure of antiretroviral treatment...
  34. ncbi Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis
    Martin W G Brinkhof
    Division of International and Environmental Health, Institute of Social and Preventive Medicine ISPM, University of Bern, Bern, Switzerland
    PLoS ONE 4:e5790. 2009
    ..The retention of patients in antiretroviral therapy (ART) programmes is an important issue in resource-limited settings. Loss to follow up can be substantial, but it is unclear what the outcomes are in patients who are lost to programmes...
  35. ncbi Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality
    Martin W G Brinkhof
    Institute of Social and Preventive Medicine ISPM, University of Bern, Switzerland
    PLoS Med 6:e1000066. 2009
    ..We compared mortality rates observed in HIV-1-infected patients starting ART with non-HIV-related background mortality in four countries in sub-Saharan Africa...
  36. ncbi [The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies]
    Erik von Elm
    Institute of Social and Preventive Medicine ISPM, University of Bern, Berna, Suiza
    Rev Esp Salud Publica 82:251-9. 2008
    ..We hope that the STROBE statement will contribute to improving the quality of reporting of observational studies...
  37. ncbi Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis
    Nicola Low
    Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
    PLoS Med 8:e1000416. 2011
    ..Secondary objectives were to investigate associations between intravaginal practices and disrupted vaginal flora; and between disrupted vaginal flora and HIV acquisition...
  38. ncbi Meta-analysis in medical research: potentials and limitations
    Marcel Zwahlen
    Department of Social and Preventive Medicine, University of Berne, Berne, Switzerland
    Urol Oncol 26:320-9. 2008
    ..We argue that meta-analyses should only be performed within the framework of systematic reviews that have been prepared using methods that minimize bias and address the combinability of studies...
  39. ncbi Mortality from neurodegenerative disease and exposure to extremely low-frequency magnetic fields: 31 years of observations on Swiss railway employees
    Martin Röösli
    Department of Social and Preventive Medicine, University of Berne, Berne, Switzerland
    Neuroepidemiology 28:197-206. 2007
    ..The objective of the present study was to investigate the relationship between extremely low-frequency magnetic field (ELF-MF) exposure and mortality from several neurodegenerative conditions in Swiss railway employees...
  40. ncbi Leukaemia, brain tumours and exposure to extremely low frequency magnetic fields: cohort study of Swiss railway employees
    Martin Röösli
    Department of Social and Preventive Medicine, University of Berne, Switzerland
    Occup Environ Med 64:553-9. 2007
    ..To investigate the relationship between extremely low frequency magnetic field (ELF-MF) exposure and mortality from leukaemia and brain tumour in a cohort of Swiss railway workers...
  41. ncbi Partner notification of chlamydia infection in primary care: randomised controlled trial and analysis of resource use
    Nicola Low
    Department of Social Medicine, University of Bristol, Bristol BS8 2PR
    BMJ 332:14-9. 2006
    ..To evaluate the effectiveness of a practice nurse led strategy to improve the notification and treatment of partners of people with chlamydia infection...
  42. ncbi A systematic review of the survival and complication rates of fixed partial dentures (FPDs) after an observation period of at least 5 years
    Bjarni E Pjetursson
    School of Dental Medicine, University of Berne, Berne, Switzerland
    Clin Oral Implants Res 15:625-42. 2004
    ..The objective of this systematic review was to assess the 5- and 10-year survival of implant supported fixed partial dentures (FPDs) and to describe the incidence of biological and technical complications...
  43. ncbi Quality of reporting of randomized trials as a measure of methodologic quality
    Karin Huwiler-Müntener
    Department of Social and Preventive Medicine, University of Bern, Switzerland
    JAMA 287:2801-4. 2002
    ..We examined the relationship between reporting quality and methodologic quality of published RCTs...
  44. ncbi Sleepless night, the moon is bright: longitudinal study of lunar phase and sleep
    Martin Röösli
    Department of Social and Preventive Medicine, University of Berne, Berne, Switzerland
    J Sleep Res 15:149-53. 2006
    ..027) at full moon. The study was designed for other purposes and the association between lunar cycle and sleep duration will need to be confirmed in further studies...
  45. ncbi Years of life lost attributable to air pollution in Switzerland: dynamic exposure-response model
    Martin Röösli
    Department of Social and Preventive Medicine, University of Bern, Switzerland
    Int J Epidemiol 34:1029-35. 2005
    ..We use the method to estimate the number of years of life lost (YLLs) attributable to air pollution during 1 year in Switzerland...
  46. ncbi A systematic review of the survival and complication rates of fixed partial dentures (FPDs) after an observation period of at least 5 years
    Bjarni E Pjetursson
    School of Dental Medicine, University of Berne, Berne, Switzerland
    Clin Oral Implants Res 15:667-76. 2004
    ..The objective of this systematic review was to assess the survival of cantilever fixed partial dentures (FPDs) and the incidence of biological and technical complications...
  47. ncbi Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries
    Martin W G Brinkhof
    Institute of Social and Preventive Medicine ISPM, University of Berne, Finkenhubelweg 11, CH 3012 Bern, Switzerland
    Clin Infect Dis 45:1518-21. 2007
    ..48 (95% confidence interval, 0.36-0.64) in low-income countries and 0.36 (95% confidence interval, 0.26-0.50) in high-income countries. A low CD4 cell count at the start of therapy was the most important risk factor in both settings...
  48. ncbi Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis
    Suzanna Attia
    Institute of Social and Preventive Medicine, University of Bern, Switzerland
    AIDS 23:1397-404. 2009
    ..To synthesize the evidence on the risk of HIV transmission through unprotected sexual intercourse according to viral load and treatment with combination antiretroviral therapy (ART)...
  49. ncbi Risk of cardiovascular events and rofecoxib: cumulative meta-analysis
    Peter Juni
    Department of Social and Preventive Medicine, University of Berne, Berne, Switzerland
    Lancet 364:2021-9. 2004
    ..We used standard and cumulative random-effects meta-analyses of randomised controlled trials and observational studies to establish whether robust evidence on the adverse effects of rofecoxib was available before September, 2004...
  50. ncbi Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies
    Simon Wandel
    Institute of Social and Preventive Medicine ISPM, University of Bern, Finkenhubelweg 11, CH 3012 Bern, Switzerland
    Sex Transm Infect 84:i31-i36. 2008
    ..Estimation of the number of people in need of antiretroviral therapy (ART) in resource-limited settings requires information on the time from seroconversion to ART eligibility and from ART eligibility to death...
  51. ncbi Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration
    Mary Ann Davies
    School of Public Health and Family Medicine, University of Cape Town
    S Afr Med J 99:730-7. 2009
    ..To assess paediatric antiretroviral treatment (ART) outcomes and their associations from a collaborative cohort representing 20% of the South African national treatment programme...
  52. ncbi Childhood leukaemia and socioeconomic status: what is the evidence?
    Martin Adam
    Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Finkenhubelweg 11, Bern CH 3012, Switzerland
    Radiat Prot Dosimetry 132:246-54. 2008
    ..Future research should minimise case and control selection bias, distinguish between different SES measures and leukaemia subtypes and consider timing of exposures and cancer outcomes...
  53. ncbi Essentials of good epidemiological practice: are guidelines following guidelines?
    Erik von Elm
    Department of Social and Preventive Medicine, University of Berne, Switzerland
    Soz Praventivmed 50:28-30. 2005
  54. ncbi Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort
    Andrew Boulle
    Infectious Disease Epidemiology Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
    Antivir Ther 12:753-60. 2007
    ..The patterns and reasons for antiretroviral therapy (ART) drug substitutions are poorly described in resource-limited settings...
  55. ncbi Routine vaccination against pertussis and the risk of childhood asthma: a population-based cohort study
    Ben D Spycher
    Institute of Social and Preventive Medicine, Finkenhubelweg 11, CH 3012 Bern, Switzerland
    Pediatrics 123:944-50. 2009
    ..A recent review stressed the need for additional, adequately controlled large-scale studies...
  56. ncbi Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization
    Stephan Windecker
    Department of Cardiology, University Hospital Bern, Bern, Switzerland
    N Engl J Med 353:653-62. 2005
    ..Sirolimus-eluting stents and paclitaxel-eluting stents, as compared with bare-metal stents, reduce the risk of restenosis. It is unclear whether there are differences in safety and efficacy between the two types of drug-eluting stents...
  57. ncbi Culture, risk factors and mortality: can Switzerland add missing pieces to the European puzzle?
    D Faeh
    Institute of Social and Preventive Medicine ISPM, University of Zurich, Hirschengraben 84, 8001 Zurich, Switzerland
    J Epidemiol Community Health 63:639-45. 2009
    ....
  58. ncbi Educational inequalities in life expectancy in German speaking part of Switzerland 1990-1997: Swiss National Cohort
    Adrian Spoerri
    Department of Social and Preventive Medicine, University of Bern, Bern, Switzerland
    Swiss Med Wkly 136:145-8. 2006
    ..6, 3.1, 2.7 and 2.2 years. CONCLUSIONS: In Switzerland educational gradients in life expectancy are substantial, particularly among young and middle-aged men. Social policies and public health strategies should address this situation...
  59. ncbi Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis
    Monika Muller
    International epidemiological Databases to Evaluate AIDS, Southern African region, Institute of Social and Preventive Medicine, University of Bern, Switzerland
    Lancet Infect Dis 10:251-61. 2010
    ..Occurrence of IRIS might therefore be reduced by initiation of ART before immunodeficiency becomes advanced...
  60. ncbi Predicting the risk of hospital admission in older persons--validation of a brief self-administered questionnaire in three European countries
    Jan T Wagner
    Department of Geriatrics, University of Bern, Bern, Switzerland
    J Am Geriatr Soc 54:1271-6. 2006
    ..The Pra is likely of high interest to governments and health insurance companies worldwide as a basis for programs aimed at health risk management in older persons...
  61. ncbi Publication and non-publication of clinical trials: longitudinal study of applications submitted to a research ethics committee
    Erik von Elm
    Institute of Social and Preventive Medicine ISPM, University of Bern, Bern, Switzerland
    Swiss Med Wkly 138:197-203. 2008
    ..We studied the publication rate of a cohort of clinical trials and identified factors associated with publication and nonpublication of results...
  62. ncbi A model for radiofrequency electromagnetic field predictions at outdoor and indoor locations in the context of epidemiological research
    Alfred Bürgi
    ARIAS umwelt forschung beratung, Bern, Switzerland
    Bioelectromagnetics 31:226-36. 2010
    ..42-0.65) for window measurements. Although the modeling of shielding effects by walls and roofs requires considerable simplifications of a complex environment, we found a comparable accuracy of the model for indoor and outdoor points...
  63. ncbi Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus: meta-analysis of randomised controlled trials
    Sabin Allemann
    Department of Social and Preventive Medicine, University of Bern, Switzerland
    Curr Med Res Opin 22:617-23. 2006
    ..CONCLUSIONS: Fibrates are associated with a substantial reduction of CHD events, but their exact role in lipid lowering treatment of patients with type 2 diabetes mellitus remains to be defined...
  64. ncbi Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials
    Julia Bohlius
    Institute of Social and Preventive Medicine ISPM, University of Bern, Bern, Switzerland
    Lancet 373:1532-42. 2009
    ..We therefore did a meta-analysis of randomised controlled trials in which these drugs plus red blood cell transfusions were compared with transfusion alone for prophylaxis or treatment of anaemia in patients with cancer...
  65. ncbi Source of funding and results of studies of health effects of mobile phone use: systematic review of experimental studies
    Anke Huss
    Department of Social and Preventive Medicine, University of Berne, Berne, Switzerland
    Environ Health Perspect 115:1-4. 2007
    ....
  66. ncbi Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study
    Eveline Nüesch
    Institute of Social and Preventive Medicine ISPM, University of Bern, Switzerland
    BMJ 341:c3515. 2010
    ..To examine the presence and extent of small study effects in clinical osteoarthritis research...
  67. ncbi The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy
    Caroline A Sabin
    ICONA, Institute of Infectious and Tropical Diseases, University of Milan, Italy
    Arch Intern Med 165:416-23. 2005
    ..CONCLUSION: Although the incidence of all AIDS-defining events decreased substantially after starting HAART, the pattern of decline was most pronounced for events with a viral etiology...
  68. ncbi What should we do about screening for genital chlamydia?
    Nicola Low
    Int J Epidemiol 31:891-3. 2002
  69. ncbi Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy
    Margaret May
    Department of Social Medicine, University of Bristol, Bristol, UK
    Stat Med 23:2375-98. 2004
    ..The methods are illustrated by using a model developed to predict progression to a new AIDS event or death in HIV-1 positive patients starting antiretroviral therapy...
  70. ncbi Antiretroviral treatment and osteonecrosis in patients of the Swiss HIV Cohort Study: a nested case-control study
    Barbara Hasse
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland
    AIDS Res Hum Retroviruses 20:909-15. 2004
    ..92 versus 2.17 years, p = 0.30). In conclusion, AVN could not be attributed to time on antiretroviral treatment, but patients with AVN had histories of more severe immunosuppression and a higher body mass index than controls...
  71. ncbi Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population
    Christian Jaggy
    Swiss Re, Zurich, Switzerland
    Lancet 362:877-8. 2003
    ..Patients with successfully treated cancer have much the same excess death rates but are not excluded from life insurance policies...
  72. ncbi CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study
    Gilbert R Kaufmann
    Basel Center for HIV Research, Division of Infectious Diseases, University Hospital, Basel, Switzerland
    Arch Intern Med 163:2187-95. 2003
    ..Treatment interruptions, a poor virologic response, and older age were the major factors negatively affecting the recovery of CD4 T lymphocytes...
  73. ncbi A systematic review of the survival and complication rates of fixed partial dentures (FPDs) after an observation period of at least 5 years. II. Combined tooth--implant-supported FPDs
    Niklaus P Lang
    School of Dental Medicine, University of Berne, Berne, Switzerland
    Clin Oral Implants Res 15:643-53. 2004
    ..The objective of this systematic review was to assess the 5- and 10-year survival of combined tooth-implant-supported fixed partial dentures (FPDs) and the incidence of biological and technical complications...
  74. ncbi Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration
    Jan P Vandenbroucke
    Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
    PLoS Med 4:e297. 2007
    ..Examples of useful flow diagrams are also included. The STROBE Statement, this document, and the associated Web site (http://www.strobe-statement.org/) should be helpful resources to improve reporting of observational research...
  75. ncbi Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials
    Yazdan Yazdanpanah
    Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, Faculte de Medecine de Lille, BP 619, F 59208 Tourcoing, France
    BMJ 328:249. 2004
    ..To compare the clinical efficacy of triple antiretroviral regimens based on protease inhibitors and non-nucleoside analogue reverse transcriptase inhibitors (NNRTIs) in adults positive for antibodies to HIV-1...
  76. ncbi MDR1 genetic polymorphism does not modify either cell permissiveness to HIV-1 or disease progression before treatment
    Gabriela Bleiber
    Institute of Microbiology and Division of Infectious Diseases, University Hospital of Lausanne, Lausanne, Switzerland
    J Infect Dis 189:583-6. 2004
    ....
  77. ncbi Opportunistic and systematic screening for chlamydia: a study of consultations by young adults in general practice
    Chris Salisbury
    Academic Unit of Primary Health Care, University of Bristol, Cotham House, Cotham Hill, Bristol BS6 6JL, UK
    Br J Gen Pract 56:99-103. 2006
    ..There are insufficient data about young peoples' use of primary care services to determine the potential coverage of opportunistic screening in comparison with a systematic population-based approach...
  78. ncbi Commentary: strengthening the reporting of observational epidemiology the STROBE statement
    Matthias Egger
    Int J Epidemiol 36:948-50. 2007
  79. ncbi Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration
    Jan P Vandenbroucke
    Leiden University Medical Center, Leiden, The Netherlands
    Ann Intern Med 147:W163-94. 2007
    ..Examples of useful flow diagrams are also included. The STROBE Statement, this document, and the associated Web site (www.strobe-statement.org) should be helpful resources to improve reporting of observational research...
  80. ncbi Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration
    Suely H Tuboi
    Infectious Diseases Epidemiology Research Unit, Graduate School of Public Health and School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    J Acquir Immune Defic Syndr 45:52-9. 2007
    ..To assess the frequency of and risk factors for discordant responses at 6 months on highly active antiretroviral therapy (HAART) in previously treatment-naive HIV patients from resource-limited countries...
  81. ncbi HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis
    Margaret T May
    Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, Bristol BS8 2PR, UK
    Lancet 368:451-8. 2006
    ..We aimed to examine trends in the characteristics of patients starting HAART in Europe and North America, and their treatment response and short-term prognosis...
  82. ncbi Cohort profile: the paediatric antiretroviral treatment programmes in lower-income countries (KIDS-ART-LINC) collaboration
    Elise Arrive
    Unité INSERM 593, Institut de Santé Publique, Epidémiologie et Développement ISPED, Universite Victor Segalen, Bordeaux, France
    Int J Epidemiol 37:474-80. 2008
  83. ncbi A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men
    Margaret May
    Department of Social Medicine, University of Bristol, UK
    Int J Epidemiol 36:1309-18. 2007
    ..We developed a prognostic model for CHD tailored to the changes in risk factors observed in patients starting HAART...
  84. ncbi Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration
    Jan P Vandenbroucke
    Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
    Epidemiology 18:805-35. 2007
    ..Examples of useful flow diagrams are also included. The STROBE Statement, this document, and the associated web site (http://www.strobe-statement.org) should be helpful resources to improve reporting of observational research...
  85. ncbi Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration
    Paula Braitstein
    Department of Medicine, Indiana University, Indianapolis, Indiana, USA
    J Womens Health (Larchmt) 17:47-55. 2008
    ....
  86. ncbi Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries
    Paula Braitstein
    Lancet 367:817-24. 2006
    ..Timely diagnosis and assessment of treatment eligibility, coupled with free provision of HAART, might reduce this excess mortality...
  87. ncbi Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies
    Margaret May
    Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, Bristol, UK
    AIDS 21:1185-97. 2007
    ..To estimate the prognosis over 5 years of HIV-1-infected, treatment-naive patients starting HAART, taking into account the immunological and virological response to therapy...
  88. ncbi Prognostic model for HIV-1 disease progression in patients starting antiretroviral therapy was validated using independent data
    Margaret May
    Antiretroviral Therapy ART Cohort Collaboration Department of Social Medicine, University of Bristol, Bristol BS8 2PR, UK
    J Clin Epidemiol 58:1033-41. 2005
    ..The objective is to validate the model on independent data from CASCADE...
  89. ncbi Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts
    Francois Dabis
    INSERM U 593, ISPED, Universite Victor Segalen, Bordeaux Cedex, France
    Int J Epidemiol 34:979-86. 2005
  90. ncbi Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study
    Jonathan A C Sterne
    Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, Bristol BS8 2PR, UK
    Lancet 366:378-84. 2005
    ....
  91. ncbi Response to highly active antiretroviral therapy at 6 months and long-term disease progression in HIV-1 infection
    Sophie Grabar
    INSERM U720, Faculté de Médecine Pitié Salpêtrière, Universite Paris VI, and Service de Biostatistique et Informatique Médicale, Hopital Cochin, Universite Paris V, Paris, France
    J Acquir Immune Defic Syndr 39:284-92. 2005
    ..To compare the long-term prognostic significance of different definitions of immunologic and virologic responses to highly active antiretroviral therapy (HAART) at 6 months...
  92. ncbi Response to combination antiretroviral therapy: variation by age
    Ian Weller
    AIDS 22:1463-73. 2008
    ..The poorer virological responses in children may increase the likelihood of emergence of resistance...
  93. ncbi Antiretroviral therapy in resource-poor settings: scaling up inequalities?
    Matthias Egger
    Int J Epidemiol 34:509-12. 2005
  94. ncbi Coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and prevalence of infection in the United Kingdom general population: cross sectional study
    John Macleod
    Department of Primary Care and General Practice, University of Birmingham, Birmingham B15 2TT
    BMJ 330:940. 2005
    ..To measure the coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and the prevalence of infection in the general population in the United Kingdom. To investigate factors associated with these measures...
  95. ncbi Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study
    Bruno Ledergerber
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital, Zurich, Switzerland
    Clin Infect Dis 45:111-9. 2007
    ..Human immunodeficiency virus (HIV)-infected persons may be at increased risk for developing type 2 diabetes mellitus because of viral coinfection and adverse effects of treatment...

Research Grants3

  1. Observational Antiretroviral Studies In Southern Africa (OASIS) Collaboration
    Matthias Egger; Fiscal Year: 2007
    ..An operational structure is proposed that emphasizes the long-term collaborative and capacity-building approach of the collaboration. ..
  2. Observational Antiretroviral Studies In Southern Africa (OASIS) Collaboration
    Matthias Egger; Fiscal Year: 2007
    ..An operational structure is proposed that emphasizes the long-term collaborative and capacity-building approach of the collaboration. ..